Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	267.77	440.93	66.43	25.78	54.72
Cash & Short-Term Investments	267.77	440.93	66.43	25.78	54.72
Cash Growth	-39.27%	563.78%	157.71%	-52.89%	-
Accounts Receivable	996.56	788.15	519.97	434.81	360.4
Other Receivables	23.57	13.09	27.85	28.08	75.42
Receivables	1,020	801.24	547.82	462.89	435.82
Inventory	2,303	1,554	1,170	931.44	826.17
Prepaid Expenses	-	0.95	2.59	1.98	1.86
Other Current Assets	1,890	1,993	1,109	387.04	309.93
Total Current Assets	5,480	4,789	2,895	1,809	1,628
Property, Plant & Equipment	5,746	4,632	4,029	3,389	2,799
Long-Term Investments	76.92	167.62	159.03	-	-
Other Intangible Assets	0.33	0.55	0.77	0.99	-
Long-Term Deferred Tax Assets	-	-	-	-	23.76
Other Long-Term Assets	-	-	-	0	-
Total Assets	11,304	9,590	7,084	5,199	4,451
Accounts Payable	23.79	44.46	42.65	20.43	34.19
Accrued Expenses	444.32	298.32	245.36	185.09	161.28
Short-Term Debt	5,008	4,066	2,682	1,143	782.7
Current Portion of Long-Term Debt	35.37	18.09	28.13	18.8	71.31
Current Portion of Leases	43.55	34.72	29.25	34.62	24.13
Current Income Taxes Payable	451.2	345.48	245.11	141.44	161.28
Other Current Liabilities	288.36	47.84	14.02	28.31	8.23
Total Current Liabilities	6,295	4,855	3,287	1,572	1,243
Long-Term Debt	225.32	120.63	171.39	162.98	60.9
Long-Term Leases	64.5	89.6	100.72	131.53	27.58
Long-Term Deferred Tax Liabilities	158.01	152.11	42.36	28.25	17.3
Other Long-Term Liabilities	-	0	-	-0	-
Total Liabilities	6,743	5,217	3,601	1,895	1,349
Common Stock	1,074	1,074	802.3	802.3	0.8
Additional Paid-In Capital	448.17	448.17	-	-	-
Retained Earnings	708.02	443.03	204.24	535.83	1,135
Comprehensive Income & Other	2,331	2,407	2,477	1,966	1,966
Shareholders' Equity	4,561	4,372	3,483	3,304	3,102
Total Liabilities & Equity	11,304	9,590	7,084	5,199	4,451
Total Debt	5,377	4,329	3,012	1,491	966.62
Net Cash (Debt)	-5,032	-3,721	-2,786	-1,466	-911.9
Net Cash Per Share	-46.85	-37.42	-34.73	-18.27	-11.37
Filing Date Shares Outstanding	107.42	107.42	80.23	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	80.23	80.23	80.23
Working Capital	-814.39	-65.55	-391.14	237.08	385.38
Book Value Per Share	42.46	40.71	43.41	41.19	38.67
Tangible Book Value	4,561	4,372	3,482	3,303	3,102
Tangible Book Value Per Share	42.46	40.70	43.40	41.17	38.67
Land	2,483	2,483	2,483	2,483	2,474
Buildings	1,415	1,142	745.82	231.9	185.08
Machinery	1,708	985.02	831.81	789.03	539.94
Construction In Progress	931.72	614.67	403.01	159.04	-

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.